NORYVA
BPC-157
The one whose work covers the widest range of tissues.
10 mg
BPC-157 is a short sequence, rebuilt from a piece of a protein the stomach makes. What drew attention is not one tissue in particular: in animals, the same sequence keeps coming back on gut, tendon and muscle.
- Tissue repair — work carried out in animals.
- Gut and digestive comfort, in animals.
- Tendons and muscles, in animals.
What is being looked at?
- Wound healing
- Recovery
- Tendons and muscles
- Digestion
The essentials
- Format
- 10 mg
- Storage · Batch number · Manufactured · Expiry · Batch purity
- On the batch certificate
- Evidence level
- Preclinical
- Use
- For research and laboratory use only.
The question you are asking yourself
If it is so promising, why is there almost nothing in humans?
That is the right question, and the answer is short: there is almost nothing. Controlled human data are extremely limited, and the literature comes from a small number of laboratories. We write it here rather than let you find it elsewhere.
Why this reference?
What drew attention is not one spectacular result on one tissue, it is the CONSISTENCY: in animals, the same sequence acts on the repair of tissues that have nothing in common. It is a serious lead, and it is also all that can be said: controlled human data are extremely limited.
What you should know
Scientific detail
What it is
BPC-157 is a synthetic fifteen-amino-acid peptide derived from a sequence identified in a human gastric juice protein. It does not exist as such in the body: it is a reconstructed fragment.
Why it is studied
It is studied for its observed effect on healing across varied tissues in animal models — tendon, muscle, intestine — with a consistency that has drawn attention.
Described mechanism
Proposed mechanism: influence on the formation of new blood vessels, notably via the VEGF pathway, and interaction with the nitric oxide system. The mechanism is not established; several pathways are proposed without any commanding consensus.
What the research has studied
- Wound healing
- Digestive models
- Tendon and muscle
Human data
This is the central point and it must be stated plainly: published, controlled human data are extremely limited. Almost all of the available literature concerns rodents. A heavily cited molecule is not a molecule demonstrated in humans.
Preclinical data
Abundant animal literature, coming largely from a small number of groups — which limits the value of the repeated findings.
What the data does not say
Absence of solid controlled human data. Concentration of publications in few laboratories. No long-term human safety assessment. BPC-157 has been the subject of authority decisions concerning its use in compounding: those decisions are not approvals and must be read for what they are — see the Science Center.
Regulatory status
For laboratory research purposes only. Not for human consumption or therapeutic use.
This reference holds no marketing authorisation as a medicinal product.
Customer reviews
Frequently asked questions
Can I order BPC-157 today?
No. This reference is not offered for sale: its commercial framework is not settled. No purchase button is shown until it is.
Does BPC-157 hold a marketing authorisation?
No. This reference holds no marketing authorisation as a medicinal product and is approved by no authority for human use. A publication or a clinical trial never amounts to approval.
What analyses are available?
The certificate of analysis is supplied with the batch delivered. No batch number or purity figure is published until the real certificate has been entered: we do not display illustrative values.
How is this reference stored?
The storage requirement is not yet on file: the supplier data sheet has not reached us. We would rather say so than assume.
Is it compatible with the NORYVA injector pen?
Compatibility is not confirmed for this reference. Until the manufacturer confirms it, we do not claim it.
What does the available data actually show?
Absence of solid controlled human data. Concentration of publications in few laboratories. No long-term human safety assessment. BPC-157 has been the subject of authority decisions concerning its use in compounding: those decisions are not approvals and must be read for what they are — see the Science Center.
Work out a volume
The vial amount is prefilled from this page. The solvent volume and the amount aimed for are yours to enter: NORYVA proposes neither.